Page last updated: 2024-09-04

gadolinium dtpa and Hypophosphatemia

gadolinium dtpa has been researched along with Hypophosphatemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bulsara, K; Chen, D; Dhib-Jalbut, S; Imitola, J; Malchoff, C; Wolansky, I; Wolansky, L; Wu, R1
Bageac, D; DeBevits, JJ; Dhib-Jalbut, S; DiCamillo, PA; Hu, C; Kaplan, J; Karimeddini, D; Munbodh, R; Naismith, RT; Wang, Y; Wolansky, L; Wu, R1

Other Studies

2 other study(ies) available for gadolinium dtpa and Hypophosphatemia

ArticleYear
Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity.
    The Journal of international medical research, 2022, Volume: 50, Issue:2

    Topics: Bone Marrow; Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypophosphatemia; Leukopenia; Magnetic Resonance Imaging; Organometallic Compounds; Retrospective Studies; Skull

2022
MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia.
    Clinical imaging, 2021, Volume: 70

    Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypophosphatemia; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies

2021